Viewing Study NCT00126061


Ignite Creation Date: 2025-12-24 @ 12:21 PM
Ignite Modification Date: 2025-12-27 @ 5:00 AM
Study NCT ID: NCT00126061
Status: COMPLETED
Last Update Posted: 2015-01-16
First Post: 2005-08-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Male Subjects
Sponsor: Solvay Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module